Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors

Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased by 7% year-on-year, despite unprecedented uncertainty in the firm’s target private equity markets. Demand for Humatica’s organizational effectiveness and efficiency services grew as both new and long-standing clients turned to the firm for support in navigating an increasingly complex operating environment. Growth was broad-based, spanning Europe and North America.

As private equity adapts to a slower deal environment and reduced capital inflows, asset managers are sharpening their focus on operational value creation to offset financial market and macro-economic headwinds. In this context, Humatica’s tech-enabled org effectiveness and efficiency services have become important levers for unlocking portfolio company performance and value.

During 1H 2025 Humatica strengthened its North American footprint with the appointment of two U.S.-based Operating Partners and a New York office. These steps enhance Humatica’s ability to provide local support for U.S. and global clients in the Americas.

The firm also scaled deployment of its AI-enabled altus behavioral benchmarking tools, applying them consistently across portfolios to set a new standard in assessing team performance and governance quality at scale.

Humatica’s outstanding achievements were recognized with multiple awards in the first half-year.
The firm won both Actum’s 2025 Value Creation Award as the best advisor for “People & Organizational Strategy” and Real Deals’ Value Creation Adviser of The Year award – each for a second time. Additionally, Humatica was named as one of the top private equity advisory firms in the UK by Consulting.uk. These honors underscore the firm’s growing reputation as a leader in delivering measurable results through organizational effectiveness and efficiency.

Andros Payne, Managing Partner of Humatica, commented:
“I’m very proud of the Humatica team that continues to deliver meaningful impact for our demanding private equity clients. What was once a specialist niche, has now become a mainstream requirement. After more than 20 years’ focus on organizational efficiency and effectiveness, it’s inspiring to see these levers at the top of the PE value creation agenda.”